deferoxamine has been researched along with Weight Gain in 3 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Weight Gain: Increase in BODY WEIGHT over existing weight.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, WJ | 1 |
| Wei, H | 1 |
| Frei, B | 1 |
| Bosque, MA | 1 |
| Domingo, JL | 1 |
| Corbella, J | 1 |
| Baker, E | 1 |
| Wong, A | 1 |
| Peter, H | 1 |
| Jacobs, A | 1 |
3 other studies available for deferoxamine and Weight Gain
| Article | Year |
|---|---|
The iron chelator, desferrioxamine, reduces inflammation and atherosclerotic lesion development in experimental mice.
Topics: Animals; Aorta; Apolipoproteins E; Atherosclerosis; Chemokine CCL2; Cholesterol; Deferoxamine; Femal | 2010 |
Assessment of the developmental toxicity of deferoxamine in mice.
Topics: Animals; Body Weight; Deferoxamine; Eating; Embryonic and Fetal Development; Female; Gestational Age | 1995 |
Desferrithiocin is an effective iron chelator in vivo and in vitro but ferrithiocin is toxic.
Topics: Administration, Oral; Animals; Aspartate Aminotransferases; Cells, Cultured; Deferoxamine; Dihydropy | 1992 |